Compare GE Vernova Inc (GEV) vs Meta Platforms Inc (META) Price & Performance

GE Vernova (GEV) stock trades at $1,021.20, down 4.2% over 24 hours, as it approaches its Q2 2026 earnings report on July 22. The technical picture is mixed, with a bearish overall signal but a bullish moving average crossover. Fundamentally, the company shows strong profitability with a 23.81% net margin and robust ROE of 83.23%, though valuation ratios like a P/E of 30.84 and EV/EBITDA of 109.82 appear elevated. Recent earnings have been volatile, with a significant beat in Q1 2026 but a miss in Q3 2025. Analyst sentiment remains overwhelmingly positive, with a 75% buy rating and a consensus price target of $1,260, representing over 23% upside. The company is positioned to benefit from AI-driven power demand and grid modernization, highlighted by recent news coverage and an $11 billion investment push.

The outlook for GEV is cautiously optimistic, driven by its leadership in power infrastructure and exposure to secular growth in AI and data center energy demand. Key opportunities include pricing power from scarce gas turbines, a massive global installed base, and growth in its nuclear segment with the BWRX-300 Small Modular Reactor. Primary risks include execution challenges in its Wind segment, high valuation multiples that leave little room for error, and potential volatility around earnings. The stock's recent decline may present a buying opportunity ahead of earnings for investors bullish on the long-term AI power theme.

META stock trades at $673.95, up 1.95% today, with strong technical momentum and bullish moving averages. The company reported robust earnings beats in recent quarters, including Q1 2026 EPS of $10.44 versus $6.70 expected, driven by revenue growth to $201.0B in 2025. Analyst sentiment is overwhelmingly positive, with a consensus price target of $807.84, though RSI levels indicate potential overbought conditions near-term.

The outlook remains favorable given META's AI advancements like Muse Spark and solid profitability, but risks include regulatory lawsuits and high capital expenditures. With 79% of analysts rating it Buy, the stock offers growth potential, though investors should monitor legal developments and valuation multiples.